Thrive Capital Management (Pennsylvania)’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
VCM
VPM
Thrive Capital Management (Pennsylvania)'s JNJ Position: Q1 2026 in Review
Thrive Capital Management (Pennsylvania) reduced its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, selling an estimated $654K and leaving 22,943 shares worth $5.61M. The position accounts for 1.23% of the portfolio, ranked #17.
Thrive Capital Management (Pennsylvania) first reported a position in JNJ in Q4 2020 and has held it in 22 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Thrive Capital Management (Pennsylvania) held 22,943 shares of Johnson & Johnson worth $5.61M as of Q1 2026.
- Thrive Capital Management (Pennsylvania) sold 2,809 Johnson & Johnson shares in Q1 2026, an estimated $654K.
- Johnson & Johnson made up 1.23% of Thrive Capital Management (Pennsylvania)'s portfolio in Q1 2026, its #17 holding.
- Thrive Capital Management (Pennsylvania) first reported a position in Johnson & Johnson in Q4 2020 and has held it in 22 quarters since.
- 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q1 2026, filed 27 Apr 2026.